QUINTA-ANALYTICA
Jiri Raska has a strong background in the pharmaceutical industry, with experience in various roles and companies. Jiri most recently worked at Conscio Group as the Chief Commercial Officer, where they contributed to the support and successful launch of innovative medicines. Prior to that, they held the same position at Quinta-Analytica, a full-service CRO, where they provided research services to pharmaceutical, biotechnology, and generic drug industries. Before that, Jiri served as the Commercial Director at FARMAK, a leading European generic APIs company, where they focused on R&D activities and contract manufacturing. Earlier in their career, they held leadership positions at IREL and LUNARIA, where they served as the Chief Operating Officer and Chief Commercial Officer, and as the Head of QC, respectively. Jiri began their career at Contipro Group as the Head of QC. Throughout their work experience, Jiri has consistently demonstrated their commitment to innovation, quality, and customer satisfaction.
Jiri Raska holds a Ph.D. in Physical Chemistry, which they obtained from the University of Pardubice. Jiri completed their doctoral studies from 1997 to 2005. In addition to their formal education, Jiri has also obtained certifications in fields outside of their academic background. In March 2023, they completed a certification called "Mastering the Complex Sale" from Growth Institute. Furthermore, in August 2020, they obtained a certification titled "The Six Morning Habits of High Performers" from LinkedIn.
QUINTA-ANALYTICA
Quinta is a GCP/GLP/GMP-certified, EMA and FDA-inspected European CRO offering in-house clinical testing, pharmaceutical analysis, CMC and R&D. Quinta specializes in clinical studies, bioanalytics, method development and quality control for both small and large molecules, human and veterinary IMPs as well as generics. We provide unrivaled expertise to worldwide pharmaceutical and biotechnological clients across the entire pharma spectrum. Quinta is part of the Conscio group with headquarters in Munich, Germany, laboratories in Czechia, Austria, Slovakia, Germany and offices in the USA. Our main service areas include: 1) Clinical Testing: With 2 in-house clinical units providing BE/BA/PK studies, with capacity for 60+40 beds. 2) Bioanalytical Testing: GLP/GCP solutions for preclinical & clinical studies, small & large molecules, BE/BA/PK. 3) Research & Development: Analytical R&D, impurities, extractables & leachables, degradation, trace studies. 4) Pharmaceutical Quality Control: GMP quality control, batch testing, stabilities, HAPIs, inhalation, API sourcing. 5) Microbiology: GMP sterile & non-sterile testing, microbial/water analyses, endotoxins, antibiotics & vitamins. 6) Biopharmaceutical Quality Control: GLP/GMP bioanalysis, CMC, characterizations of peptide & protein IMPs, biosimilars. Quinta was founded in 1997 and has been successfully inspected by FDA more than 10 times. Quinta is headquartered in Prague, Czech Republic.